Understanding what causes behavioral symptoms in Alzheimer's disease
Official title: Biological and environmental factors driving behavioral symptoms in Alzheimer's disease
Funded at University of Texas Hlth Sci Ctr Houston · NIH-10888131 · Data updated 2026-11-12
This study is looking at how different personal and environmental factors affect the behaviors of people with Alzheimer's disease, so we can better understand why some experience certain symptoms while others do not, and ultimately improve their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 23, 2019 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $546,583 |
| NIH project number | 5R01MH121928-07 |
| Project ID | NIH-10888131 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who experience behavioral symptoms.
✕Less likely to help
Patients with Alzheimer's disease who do not exhibit behavioral symptoms may not benefit from this research.
What this research studies
This research investigates how various biological and environmental factors influence the behavioral symptoms experienced by patients with Alzheimer's disease. By examining personal characteristics, environmental stressors, and disease-related factors, the study aims to identify why some patients experience certain symptoms while others do not. The research will utilize daily reports from patients to analyze the variability in symptoms over time, helping to uncover the underlying mechanisms that contribute to these behaviors. Ultimately, the goal is to improve treatment and management strategies for Alzheimer's patients based on these findings.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and management strategies for behavioral symptoms in Alzheimer's disease.
How similar studies have gone: Previous research has shown that understanding the interplay of biological and environmental factors can lead to significant advancements in managing behavioral symptoms in dementia.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Pickering, Carolyn E Ziminski — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Pickering, Carolyn E Ziminski
Related research
Other NIH-funded projects on the same topics.
-
Improving Communication to Help Residents with Alzheimer's Disease in Long-Term Care
This project helps nursing home staff learn better ways to talk with residents who have Alzheimer's disease and other dementias, aiming to make residents feel more comfortable and reduce challenging behaviors.
-
New treatment using engineered bacteria for cognitive and behavioral symptoms of Alzheimer's disease
This study is testing a new treatment using specially modified bacteria to help improve early symptoms of Alzheimer's, like memory problems, anxiety, and depression, with the hope of making life better for those in the early stages of the disease.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.